Performance of non-invasive prenatal testing when fetal cell-free DNA is absent
- PMID: 25358606
- PMCID: PMC4302254
- DOI: 10.1002/uog.14715
Performance of non-invasive prenatal testing when fetal cell-free DNA is absent
Comment in
-
A flawed challenge but valid recommendation: a response to Takoudes and Hamar.Ultrasound Obstet Gynecol. 2015 Jan;45(1):117. doi: 10.1002/uog.14739. Ultrasound Obstet Gynecol. 2015. PMID: 25557844 No abstract available.
-
Concerns with performance of screening for aneuploidy by cell-free DNA analysis of maternal blood in twin pregnancy.Ultrasound Obstet Gynecol. 2016 Jan;47(1):124-5. doi: 10.1002/uog.14938. Epub 2015 Nov 17. Ultrasound Obstet Gynecol. 2016. PMID: 26148199 No abstract available.
References
-
- Quezada MS, Gil MM, Francisco C, Otosz G, Nicolaides KH. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks. Ultrasound Obstet Gynecol. 2015;45:36–41. - PubMed
-
- Jackson J, Hamar B, Lazar E, Lim K, Rodriguez D, Stock K, Wolfberg AJ, Dunk R. Nuchal translucency measurement plus non-invasive prenatal testing to screen for aneuploidy in a community-based average-risk population. Ultrasound Obstet Gynecol. 2014;44:491. - PubMed
-
- Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013;33:1–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
